Harley-Davidson has just printed its Q1 earnings — and the setup that made the pre-event note compelling has now resolved, leaving a stock down 8% on the week trading at $23.36 with short sellers broadly flat and options positioning making a sharp reversal back toward defensiveness.
The most striking change in the data is what happened to that bullish options call that drove the pre-earnings narrative. The put/call ratio was at 0.88 ahead of the May 21 print — the most call-heavy reading of the past year, more than three standard deviations below its 20-day average. It has since collapsed back toward neutral, with the PCR now running at 0.88 on May 19 data — but that pre-event rotation appears to have been the high-water mark for bull enthusiasm. The 20-day average PCR of 1.53 tells the longer story: for most of the past month, this has been a stock where downside hedges dominate. The brief call spike was an event-driven bet, not a structural shift in sentiment.
Short interest tells a more nuanced story than the price action implies. Bears covered aggressively through mid-May — SI fell roughly 29% over the prior month, dropping from a peak above 18% of the float in mid-April to around 11.5% currently. That is still a meaningful short position, and the week-on-week change is essentially flat, down less than 1%. The direction of the larger covering wave has stalled. Borrow conditions remain loose: cost to borrow is just 0.52% annually and availability is running at approximately 271% of short interest, meaning the lending pool is far from stressed. Bears can add or cover with minimal friction. That is not the profile of a stock facing squeeze pressure; it is one where shorts are comfortable holding.
The Street is split, but skewed cautious. Morgan Stanley's Adam Jonas raised his target to $15 from $12 just this week — a lift, but the destination is still a significant discount to the current $23.36 price, and the Underweight rating is unchanged. UBS moved to $26 earlier in the month, Citigroup to $26, Wells Fargo to $19 — all maintaining neutral-to-negative ratings. The mean price target across the panel sits at $25.45, which implies modest upside from current levels, but the skew within that average matters: multiple firms carrying Underweight or Neutral anchors pulls the distribution toward caution. The EPS momentum factor score ranks in the 99th percentile — the company has been beating estimates convincingly — but forward EPS growth expectations are only in the 22nd percentile, suggesting the beat cycle may not translate into acceleration. The P/E has compressed around 30 points over the past month to 25x, consistent with a stock digesting a weak price run despite decent near-term results.
The earnings reaction history is worth noting. The last two prints produced positive 1-day moves: +6.6% in May 2026 and +2.7% in the prior period, with five-day follow-through of +7.6% and +9.1% respectively. The stock's Q1 reaction has gone the other way this week — down 4% on the day and down nearly 8% over five days — suggesting the market either found something in the details that the headline beat obscured, or that the 29% short-cover rally into earnings had already extracted the easy gains.
The institutional picture offers limited fresh signal. Vanguard and BlackRock together hold just over 20% of shares outstanding with minor recent changes. American Century's position is notable — up 445,000 shares in the most recent filing period — but that data reflects April 30 reporting and may predate the latest price weakness. The CEO, Artie Starrs, bought 15,000 shares at $19.10 back in early March, a price well below where the stock traded through most of April and early May. That on-paper gain has now largely reversed. No material open-market buying has followed.
What to watch: the next meaningful read will be whether short interest resumes its covering trend or plateaus at the current 11.5% level — a stall here, combined with a PCR drifting back toward the 1.5+ range that has characterised the past month, would signal that the post-earnings bounce thesis has been shelved and the bear case around tariff headwinds and margin compression is regaining traction.
See the live data behind this article on ORTEX.
Open HOG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
